Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details)

v3.20.2
NON CONTROLLING INTEREST (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2020
Sep. 30, 2019
Balance, December 31, 2019             $ (81,178)  
Net loss $ (785,172) $ (738,479) $ (1,078,188) $ (1,033,831) $ (2,040,958) $ (1,770,479) (2,601,839) $ (4,845,268)
Average Non-controlling interest percentage of profit/losses 24.20%             24.20%
Net loss attributable to the non-controlling interest $ (2,925)           (32,179) $ (4,380)
Balance, September 30, 2020             (113,357)  
BioCorRx Pharmaceuticals, Inc [Member]                
Net loss $ (72,360)           $ (132,971)  
Average Non-controlling interest percentage of profit/losses 24.20%           24.20%  
Net loss attributable to the non-controlling interest $ (17,511)           $ (32,179)